Specialty
Cardiology (heart)
Spoken Languages
English

Biography

Dr Richard Grocott-Mason trained at Jesus College, Oxford and St Thomas’ Hospital Medical School in London, qualifying in 1986. He trained in cardiology and general medicine at numerous hospitals, including:

  • King’s College Hospital
  • The London Chest Hospital
  • Guy’s Hospital 
  • Harefield Hospital 
  • University of Wales College of Medicine, Cardiff.

In 1999, he was appointed as consultant cardiologist at Hillingdon Hospital and Harefield Hospital. He combined his clinical work with clinical leadership roles, first as the clinical director of medicine and then as joint medical director and responsible officer for The Hillingdon Hospitals NHS Foundation Trust.  

In 2014 he was appointed as director of the Harefield Hospital heart division. 

In December 2015 he took over from Professor Tim Evans as the interim medical director and responsible officer of the Royal Brompton & Harefield NHS Foundation Trust. He was appointed to the permanent post in June 2016.

He has a passionate interest in ensuring that patients receive a high-quality clinical service, and is always looking at innovative ways to deliver and improve clinical services.  

Areas of expertise

Dr Grocott-Mason has been a consultant cardiologist for over 19 years, and has a wide experience in general adult cardiology, including the assessment of:

He is also an interventional cardiologist performing coronary angioplasty and is an active member of the primary angioplasty rota at Harefield Hospital.

Publications

Dr Grocott-Mason has published over 60 papers and case reports over his career on topics ranging from basic science to long-term outcomes from cardiac transplantation and aortic valve replacement.


Private patient referral 

If you would like to make an appointment with this specialist for private care, contact the RB&HH Specialist care team


Research Publications

Primary percutaneous coronary intervention (PPCI) has been shown to be the most effective treatment in restoring the coronary blood flow of patients with an ST-segment elevation myocardial infarcti